---
title: "BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares"
description: "Peter Altman, CEO of BioCardia Inc., announced the acquisition of common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies a"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254463703.md"
published_at: "2025-08-25T13:30:51.000Z"
---

# BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

> Peter Altman, CEO of BioCardia Inc., announced the acquisition of common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. The original content was published via EDGAR on August 25, 2025.

Peter Altman, President and CEO of BioCardia Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-027633), on August 25, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BCDA.US - BioCardia](https://longbridge.com/en/quote/BCDA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CEO Altman Acquires 50,104 Of BioCardia Inc [BCDA] | CEO Altman of BioCardia Inc acquired 50,104 shares, as disclosed in a Form 4 filed with the SEC. The transaction include | [Link](https://longbridge.com/en/news/269319142.md) |
| CFO McClung Acquires 28,937 Of BioCardia Inc [BCDA] | BioCardia Inc's CFO, McClung David, filed a Form 4 with the SEC, revealing changes in ownership. On December 8, 2025, he | [Link](https://longbridge.com/en/news/269319146.md) |
| BioCardia präsentiert neue Echokardiographie-Daten aus der CardiAMP-HF-Studie | BioCardia Inc. announced that new echocardiography results from the CardiAMP HF clinical trial for cell therapy in heart | [Link](https://longbridge.com/en/news/274660260.md) |
| Cellular therapy developer BioCardia's Q3 net loss narrows | BioCardia reported a Q3 net loss of $1.5 million, down from $1.7 million last year. The company secured $6 million in fi | [Link](https://longbridge.com/en/news/265592247.md) |
| BioCardia Enrolls First Patient in Phase 3 CardiAMP HF II Cell Therapy Trial | BioCardia Inc. has announced the enrollment of its first patient in the Phase 3 CardiAMP HF II clinical trial at the Uni | [Link](https://longbridge.com/en/news/263513148.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.